Ocular parasitoses and their immunology

Ocular Immunology and Inflammation

Volumn 19, Issue 6, 2011, Pages 385-396

  Laxmanappa Hoti, Suggerappa ^a,b   Tandon, Veena ^a,b  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

^b NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

eye diseases; helminths; immunity; parasites; protozoa

Indexed keywords

ACANTHAMOEBA KERATITIS; ACANTHOCEPHALA; ANGIOSTRONGYLIASIS; CESTODIASIS; DIROFILARIASIS; EYE INFECTION; HUMAN; LEISHMANIASIS; LOIASIS; ONCHOCERCIASIS; PARASITOSIS; REVIEW; TOXOCARIASIS; TOXOPLASMOSIS; TREMATODIASIS;

ANIMALS; EYE INFECTIONS, PARASITIC; FEMALE; HELMINTHIASIS; HUMANS; LEISHMANIASIS; MALE; MICE; RATS;

EID: 81855184624     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.626141     Document Type: Review

References (139)

1. Grüntzig J. Clinical features and pathology of parasitic infections of the human eye. In: H., Melhorn, ed. Parasitology in Focus: Facts and Trends. Berlin: Springer-Verlag; 1988: 591-606.
2. Vercruysse J, Taraschewski H, Pc Voigt WP. (1988). Main clinical and pathological signs of parasitic infections in domestic animals. In: Parasitology in Focus, Facts and Trends. (Ed. H. Mehlhorn), Springer Verlag Berlin Heidelberg, pp 477-537.
3. Rathinam SR, Ashok KA. Ocular manifestations of systemic disease: ocular parasitosis. Curr Opin Ophthalmol. 2010; 21:478-484.
4. Dodds EM. Toxoplasmosis. Curr Opin Ophthalmol. 2006; 17:557-561.
5. Commodaro AG, Belfort RN, Rizzo LV, et al. Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz. 2009;104:345-350.
6. Arevalo JF, Belfort R Jr, Muccioli C, et al. Ocular toxoplasmosis in the developing world. Int Ophthalmol Clin. 2010; 50:57-69.
7. Talabani H, Mergey T, Yera H, et al. Factors of occurrence of ocular toxoplasmosis: a review. Parasite. 2010; 17:177-182.
8. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 1997; 158:3557-3560.
9. Lyons RE, Anthony JP, Ferguson DJP, et al. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor b and a protective role for interleukin-6. Infect Immun. 2001; 69:2589-2595.
10. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired OT in the murine model, protective role of TNF- and IFN-?. Exp Parasitol. 1994; 78:217-229.
11. Lu F, Huang S, Kasper LH. Interleukin-10 and pathogenesis of murine OT. Infect Immun. 2003; 71:7159-7163.
12. Ophthalmologic manifestations of toxoplasmosis, 10 Jan 2011. emedicine.medscape.com/article/1204441-overview.
13. Lu F, Huang S, Kasper LH. CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis. Infect Immun. 2004 72: 4966-4972.
14. Gazzinelli RT, Brézin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-a and IFN-?. Exp Parasitol. 1994;78: 217-229.
15. Olle P, Bessieres MH, Malecaze F, Seguela JP. The evolution of ocular toxoplasmosis in anti-interferon gamma treated mice. Curr Eye Res. 1996; 15: 701-707.
16. Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol. 2007; 14(2):53-60.
17. Anger C, Lally JM. Acanthamoeba: a review of its potential to cause keratitis, current lens care solution disinfection standards and methodologies, and strategies to reduce patient risk. Eye Contact Lens. 2008; 34(5):247-253. Erratum in: Eye Contact Lens. 2008; 34(6):342.
18. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009; 148(4):487-499.
19. Visvesvara GS. Amoebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Curr Opin Infect Dis. 2010; 23(6):590-94.
20. Gopinathan U, Sharma S, Garg P, et al. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol. 2009; 57(4):273-79.
21. Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microb Infect. 2006; 8: 1400-1405.
22. Van Klink F, Taylor WM, Alizadeh H, Jager MJ, Van Rooijen N, Niederkorn JY. The role of macrophages in Acanthamoeba keratitis, Invest Ophthalmol Vis Sci. 1996;37:1271-1281.
23. Marciano-Cabral F, Toney DM. The interaction of Acanthamoeba spp. with activated macrophages and with macrophage cell lines. J. Eukaryot Microbiol. 1998; 45:452-458.
24. Stewart GL, Kim I, Shupe K, et al. Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite, J Parasitol. 1992; 78: 849-855.
25. Hurt M, Apte S, Leher H, et al. Exacerbation of Acanthamoeba keratitis in animals treated with antimacrophage inflammatory protein 2 or antineutrophil antibodies. Infect Immun. 2001;69: 2988-2995.
26. MathersW, Stevens G Jr, RodriguesM, et al. Immunopathology and electron microscopy of Acanthamoeba keratitis. Am J Ophthalmol. 1987;103: 626-635.
27. Hurt M, Proy V, Niederkorn JY, Alizadeh H. The interaction of Acanthamoeba castellanii cysts with macrophages and neutrophils. J Parasitol. 2003; 89: 565-572.
28. Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci. 2005; 46:2472-2478.
29. Said NA, Shoeir AT, Panjwani N, Garate M, Cao Z. Local and systemic humoral immune response during acute and chronic Acanthamoeba keratitis in rabbits. Curr Eye Res. 2004; 29:429-439.
30. Leher H, Zaragoza F, Taherzadeh S, Alizadeh H, Niederkorn JY. Monoclonal IgA antibodies protect against Acanthamoeba keratitis. Exp Eye Res. 1999; 69:75-84.
31. Niederkorn JY. The role of the innate and adaptive immune responses in Acanthamoeba keratitis. Arch Immunol Ther Exp (Warsz). 2002; 50: 53-59.
32. Leher H, Silvany R, Alizadeh H, Huang J, Niederkorn JY. Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun. 1998; 66: 5-10.
33. Hurt M, Niederkorn J, Alizadeh H. Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003; 44: 3424-3431.
34. Ren M, Gao L, Wu X. TLR4: The receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. Immunol Cell Biol. 2010; 88:529-536.
35. Ren MY, Wu XY. Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba keratitis. Parasite Immunol. 2011; 33:25-33.
36. Alizadeh H, Neelam S, Niederkorn JY. Role of activated macrophages in Acanthamoeba keratitis. J Parasitol. 2007; 93:1114-1120.
37. Veraldi S, Bottini S, Currò N, et al. Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis. Int J Infect Dis. 2010; 14(3):e230-e232.
38. Meenken C, Agtmael V, Michiel A, et al. Fulminant ocular Leishmaniasis in an HIV-1 positive patient. AIDS. 2004;10: 1485-1486.
39. García-Alonso M, Blanco A, Reina D, Serrano FJ, Alonso C, et al Immunopathology of the uveitis in canine leishmaniasis. Parasite Immunol. 1996;18:617-623.
40. Ament CS, Young LH. Ocular manifestations of helminthic infections: onchocersiasis, cysticercosis, T oxocariasis, and diffuse unilateral subacuteneuroretinitis. Int Ophthalmol Clin. 2006; 46(2):1-10.
41. Sabrosa NA, Cunningham ET Jr, Arevalo JF. Ocular nematode and trematode infections in the developing world. Int Ophthalmol Clin. 2010; 50(2):71-85.
42. Gorezis S, Psilla M, Asproudis I, et al. Intravitreal dirofilariasis: a rare ocular infection. Orbit. 2006; 25(1):57-59.
43. Tavakolizadeh S, Mobedi I. Orbital dirofilariasis in Iran: a case report. Korean J Parasitol. 2009; 47(4):397-399.
44. Dissanaike AS, Abeyewickreme W, Wijesundera MD, et al. Human dirofilariasis caused by Dirofilaria (Nochtiella) repens in Sri Lanka. Parasitologia. 1997; 39(4):375-382.
45. Gautam V, Rustagi IM, Singh S, et al. Subconjunctival infection with Dirofilaria repens. Jpn J Infect Dis. 2002; 55(2):47-48.
46. Nath R, Gogoi R, Bordoloi N, et al. Ocular dirofilariasis. Indian J Pathol Microbiol. 2010; 53(1):157-159.
47. Rohela M, Jamaiah I, Hui TT, et al. Dirofilaria causing eye infection in a patient from Malaysia. Southeast Asian J Trop Med Publ Health. 2009; 40(5):914-918.
48. Fodor E, Fok E, Maka E, et al. Recently recognized cases of ophthalmofilariasis in Hungary. Eur J Ophthalmol. 2009; 19(4):675-678.
49. emedicine.medscape.com/article/236698-overview- Dirofilariasis. Curr Opin Ophthalmol. 2010; 21(6): 478-484.
50. Simón F, López-Belmonte J, Marcos-Atxutegi C, et al. What is happening outside North America regarding human dirofilariasis? Vet Parasitol. 2005;24(133):181-189.
51. Bazzocchi C, Ceciliani F, McCall J W, et al Antigenic role of the endosymbionts of filarial nematodes: IgG response against the Wolbachia surface protein in cats infected with Dirofilaria immitis. Proc R Soc Lond B Biol Sci. 2000; 267: 2511-2516.
52. Kluxen G, Hörauf A. Ocular onchocerciasis: a key role for Wolbachia. Ophthalmologe. 2007; 104(10):860-865.
53. Kluxen G, Hoerauf A. The significance of some observations on African ocular Onchocerciasis described by Jean Hissette (1888-1965). Bull Soc Belge Ophtalmol. 2008; 307:53-58.
54. Little MP, Breitling LP, Basáñez MG, et al. Association between microfilarial load and excess mortality in Onchocerciasis: an epidemiological study. Lancet. 2004; 363(9420):1514-1521.
55. Sallo F, Eberhard ML, Fok E, et al. Zoonotic intravitreal Onchocerca in Hungary. Ophthalmology. 2005; 112(3):502-504.
56. Neto GH, Jaegger K, Marchon-Silva V, et al. Eye disease related to onchocerciasis: a clinical study in the Aratha-ú, Yanomami Tribe, Roraima State, Brazil. Acta Trop. 2009; 112(2):115-119.
57. Otranto D, Sakru N, Testini G, et al. Case report: first evidence of human zoonotic infection by Onchocerca lupi (Spirurida, Onchocercidae). Am J Trop Med Hy. 2011; 84(1):55-58.
58. Hall LR, Pearlman E. Pathogenesis of onchocercal keratitis (river blindness). Clin Microbiol Rev. 1999;12:445-453.
59. Pearlman, Hall LR. Immune mechanisms in Onchocerca volvulus mediated corneal disease (river blindness). Parasite Immunol. 2000; 22: 625-631.
60. Garner A. Pathology of ocular onchocerciasis: human and experimental. Trans R Soc Trop Med Hyg. 1976; 70:374-377.
61. Chan CC, Nussenblatt RB, Kim MK, et al. Immunopathology of ocular onchocerciasis, 2: anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology. 1987; 94: 439-443.
62. Pearlman E. Experimental onchocercal keratitis. Parasitol Today 1996; 12:261-267.
63. Donnelly JJ, Rockey JH, Bianco AE, et al Ocular immunopathologic findings of experimental onchocerciasis. Arch Ophthalmol. 1984; 102: 628-634.
64. Chakravarti B, Herring TA, Lass JH, et al. Infiltration of CD4+ T cells into cornea during development. Cell Immunol. 1994; 159:306-314.
65. Gallin MY, Murray D, Lass JH, et al. Experimental interstitial keratitis induced by Onchocerca volvulus antigens. Arch Ophthalmol. 1988;106: 1447-1452.
66. Pearlman E, Lass JH, Bardenstein DS, et al Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med. 1995;182: 931-940.
67. Pearlman E, Diaconu E, Hazlett FE Jr, et al. Identification of an epitope of a recombinant Onchocerca volvulus protein that induces corneal pathology. Mol Biochem Parasitol. 1997; 89:123-135.
68. Pearlman E, Lass JH, Bardenstein DS, et al Onchocerca volvulus- mediated keratitis: cytokine production by IL-4-deficient mice. Exp Parasitol 1996;84:274-281.
69. Pearlman E, Hall LR, Higgins AW, et al. The role of eosinophils and neutrophils in helminth-induced keratitis. Invest Ophthalmol Visual Sci. 1998; 39:1176-1182.
70. Daehnel K, Gillette-Ferguson I, Hise AG, et al Filaria Wolbachia activation of dendritic cells and development of Th1-associated responses is dependent on Toll-like receptor 2 in a mouse model of ocular onchocerciasis (river blindness). Parasite Immunol. 2007;29:455-465.
71. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol. 2006; 90:103-108.
72. Hise AG, Gillette-Ferguson I, Pearlman E. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for TLR4 and endosymbiotic Wolbachia bacteria. J Endotoxin Res 2003;9:390-394.
73. Jaksche A, Wessels L, Martin S, et al. Ocular involvement in systemic LoalLoa filariasis: case report and review of the literature. Ophthalmologe. 2004; 101(9):931-934.
74. Ali S, Fisher M, Juckett G. The African eye worm: a case report and review. J Travel Med. 2008; 15(1):50-52.
75. Aiello F, Palma S, Varesi C, et al. A rare case report of Loa loa ocular filariasis. Eur J Ophthalmol. 2010;20(1):237-239.
76. Padgett JJ, Jacobsen KH. Loiasis: African eye worm. Trans R Soc Trop Med Hyg. 2008;102(10):983-989.
77. Barua P, Barua N, Hazarika NK, et al. Loa loa in the anterior chamber of the eye: a case report. Indian J Med Microbiol. 2005; 23:59-60.
78. Akue JP, Hommel M, Devaney E. IgG subclass recognition of Loa loa antigens and their correlation with clinical status in individuals from Gabon. Parasite Immunol. 1998; 20:387-393.
79. Winkler S, Willheim M, Baier K, et al Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg. 1999; 60:680-686.
80. Garraud O, Nkenfou C, Bradley JE, et al. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol. 1995; 155:1316-1325.
81. Otranto D, Dantas-Torres F, Mallia E, et al. Thelazia callipaeda (Spirurida, Thelaziidae) in wild animals: report of new host species and ecological implications. Vet Parasitol. 2009; 166(3-4):262-267.
82. Malacrida F, Hegglin D, Bacciarini L, et al. Emergence of canine ocular Thelaziosis caused by Thelazia callipaeda in southern Switzerland. Vet Parasitol. 2008; 157(3-4):321-327.
83. Giangaspero A, Traversa D, Otranto D. Ecology of Thelazia spp. in cattle and their vectors in Italy. Parassitologia. 2004; 46(1-2):257-259.
84. Janjetovic Z, Arar ZV, Marinic M, et al. Uveitis caused by Toxocara canis. Acta Med Croatica. 2006; 60(1):63-66.
85. Rubinsky-Elefant G, Hirata CE, Yamamoto JH, et al. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010; 104(1):3-23.
86. Sabrosa NA, De Souza EC. Nematode infections of the eye: toxocariasis and diffuse unilateral subacuteneuroretinitis. Curr Opin Ophthalmol. 2001; 12(6):450-454.
87. Fomda BA, Ahmad Z, Khan NN, et al. Ocular toxocariasis in a child: a case report from Kashmir, north India. Indian J Med Microbiol. 2007; 25(4):411-412.
88. Sorvillo F, Ash LR, Berlin OG, et al. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerg Infect Dis. 2002; 8(4):355-359.
89. Kayes, SG., Omholt EP Grieve RB Immune responses of CBA/J mice to graded infections with Toxocara canis. Infect Immun. 1985;48: 697-703.
90. Byers B, Kimura S, Uveitis after death a larva in vitreous cavity. Am J Opthalmol. 1974;77:63-66.
91. Obwaller A., Jensen-Jarolim E, Auer H, et al. Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunol. 1998; 20:311-317.
92. Liotet S, Bloch-Michel E, Petithory JC, et al Biological manifestations of the vitreous in intraocular parasitosis: preliminary study. Int Ophthalmol. 1992; 16:75-80.
93. Butterworth AE. The eosinophil and its role in immunity to helminth infection. In: Current Topics in Immunology and Microbiology, Heidelberg: Springer Verlag; 1977:127.
94. Rockey JH, Donnelly JJ, Stromberg BE, et al Immunopathology of Toxocara canis and Ascaris suum infections of the eye: the role of the eosinophil. Invest Ophthalmol Visual Sci. 1979; 18: 1172-1184.
95. Sawanyawisuth K, Kitthaweesin K, Limpawattana P, et al. Intraocular angiostrongyliasis: clinical findings, treatments and outcomes. Trans R Soc Trop Med Hyg. 2007; 101(5):497-501.
96. Sawanyawisuth K, Sawanyawisuth K. Treatment of angiostrongyliasis. Trans R Soc Trop Med Hyg. 2008; 102(10):990-996.
97. Sawanyawisuth K, Kitthaweesin K. Optic neuritis caused by intraocular angiostrongyliasis. Southeast Asian J Trop Med Public Health. 2008;39(6):1005-1007.
98. Mattis A, Mowatt L, Lue A, et al. Ocular angiostrongyliasis: first case report from Jamaica. West Indian Med J. 2009; 58(4):383-385.
99. Diao Z, Wang J, Qi H, et al. Human ocular Angiostrongyliasis: a literature review. Trop Doct. 2011; 41(2):76-78.
100. Parikh RS, Parikh SR, Thomas R. Hookworm infestation. Comment on: Ophthalmology. 2007: 114(3):450-453.
101. Gandolf AR, Atkinson MW, Gemensky AJ, et al. Intraocular nematodiasis caused by Parelapho strongylustenuis in an eland antelope (Taurotragusoryx). J Zoo Wildl Med. 2003;34(2):194-199.
102. Ophthalmology. 2008: 115(1):224; author reply 224
103. Imai DM, Nadler SA, Brenner D, et al. Rhabditid nematodeassociated ophthalmitis and meningoencephalomyelitis in captive Asian horned frogs (Megophrysmontana). J Vet Diagn Invest. 2009; 21(4):568-573.
104. Haustein T, Lawes M, Harris E, et al. An eye-catching acanthocephalan. Clin Microbiol Infect. 2010; 16(6):787-788.
105. Hoffman GL. Incidental aquatic zoonoses. J Wildl Dis. 1970; 6(4):272.
106. Gutierrez Y, Grossniklaus HE, Annable WL. Human conjunctivitis caused by the bird parasite Philophthalmus. Am J Ophthalmol. 1987; 104(4):417-419.
107. Lamothe-Argumedo R, Diaz-Camacho SP, Nawa Y. The first human case in Mexico of conjunctivitis caused by the avian parasite, Philophthalmus lacrimosus. J Parasitol. 2003;89(1):183-185.
108. Wootten R. Observations on strigeidmetacercariae in the eyes of fish from Hanning field reservoir, Essex, England. J Helminthol. 1974; 48(1): 73-83.
109. Hubert V, Justine JL. Preliminary study of fish parasites in the Parisian region. Bull Fr Parasitol. 1990; 8:283-288.
110. McCloughlin T, Irwin S. The occurrence of eye flukes in fish from the Erne catchment area. Ir Nat J. 1991; 23:409-414.
111. Velasquez CC. Observations on the life cycle of Carneophallus brevicaeca (Africa et Garcia 1935) comb. n. (Digenea: Microphallidae). J Parasitol. 1975;61:910-914.
112. Chen HT. Systematic consideration of some heterophytid rematodes in the subfamilies Haplorchinae and Stellantchasminae. Ann Trop Med Parasitol. 1949(3-4); 43:304-312.
113. Velasquez CC. Observations on some heterophyids (Trematoda: Digenea) encysted in Philippine fishes. J Parasitol. 1973; 59(1):77-84.
114. Rathinam SR, Usha KR, Rao NA. Presumed trematode-induced granulomatous anterior uveitis: a newly recognized cause of intraocular inflammation in children from south India. Am J Ophthalmol. 2002; 133(6):773-779.
115. Jayakumar D, Kavitha S, Rathinam S, et al. Geomapping of trematode-induced granulomatous anterior uveitis: a newly identified cause of blindness among children in the Pudukkottai district of the Tamil Nadu State, India. Geospat Health. 2009; 4(1):55-63.
116. Hsu PK. A new trematode of the genus Procerovum from ducks and chickens in Canton (Trematoda: Heterophyidae). Peking Nat Hist Bull. 1950; 19:39-43.
117. Umadevi K, Madhavi R. Observations on the morphology and life-cycle of Procerovumvarium (Onji&Nishio, 1916) (Trematoda: Heterophyidae). Syst Parasitol. 2000; 46(3):215-225.
118. Jakobiec FA, Gess L, Zimmerman LE. Granulomatous dacryoadenitis caused by Schistosoma haematobium. Arch Ophthalmol. 1977; 95(2):278-280.
119. Zhou L, Luo L, You C, et al. Multiple brain hemorrhages and hematomas associated with ectopic fascioliasis in brain and eye. Surg Neurol. 2008; 69(5):516-521.
120. Angotti-Neto H, Gonçalves AC, Moura FC, et al. Extraocular muscle cysticercosis mimicking idiopathic orbital inflammation: case report. Arq Bras Oftalmol. 2007;70(3):537-539.
121. Prasad R, Bagri N, Mishra OP, et al. Proptosis of eyeball in children with medial rectus cysticercosis: report of 2 cases. Eur J Ophthalmol. 2010; 20(1):240-242.
122. Ratra D, Phogat C, Singh M, et al. Intravitreal cysticercosis presenting as neovascular glaucoma. Indian J Ophthalmol. 2010; 58(1):70-73.
123. Cárdenas F, Plancarte A, Quiroz H, et al. Taenia crassiceps: experimental model of intraocular cysticercosis. Exp Parasitol. 1989;69:324-329.
124. Flisser A, Pérez-Montfort R, Larralde C. The immunology of human and animal cysticercosis: a review. Bull World Health Organ. 1979; 57(5): 839-856.
125. Finkelman FD, Shea-Donohue T, Goldhill J, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol. 1997;15:505.
126. Urban JF Jr, Maliszewski CR, Madden KB et al. IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunode?cient mice. J Immunol. 1995;154:4675.
127. Toenjes SA, Spolski RJ, Mooney KA, et al The systemic immune response of BALB/c mice infected with larval Taenia crassiceps is a mixed Th1/Th2-type response. Parasitology. 1999; 118:623.
128. Terrazas L I, Bojalil R, Govezensky T et al. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol. 1998; 84:74.
129. Terrazas LI,Cruz M,Rodriguez-Sosa M, et al Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol Res. 1999;85: 135.
130. Rodriguez-Sosa M, David JR, Bojalil R, et al. Susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J Immunol. 2002;168:3135-3139.
131. Alonso-Trujillo J, Rivera-Montoya I, Rodríguez-Sosa M, et al. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis. Parasitol Res. 2007; 100:1341-1350.
132. Rodríguez-Sosa M, Rosas LE, David JR, et al. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun. 2003; 71:1247-1254.
133. Amit P, Prasad KN, Kumar GR, et al 2011. Immune response to different fractions of Taenia solium cyst fluid antigens in patients with neurocysticercosis. Exp Parasitol. 2011; 127:687-692.
134. Schallenberg M, Gök M, Katsounas A, et al. Keratitis caused by infection with Echinococcus granulosus. KlinMonblAugenheilkd. 2007; 224(3):213-215.
135. Murthy R, Honavar SG, Vemuganti GK, et al. Polycystic echinococcosis of the orbit. Am J Ophthalmol. 2005; 140(3): 561-563.
136. Yazdani N, Basam A, Heidarali M, et al. Infratemporal hydatid cyst: a case presenting with blindness. J Laryngol Otol. 2010; 124(4):456-459.
137. Mukherjee B, Biswas J, Raman M. Subconjunctival larva migrans caused by sparganum. Indian J Ophthalmol. 2007;55(3):242-243.
138. Zhang W, Ross AG, McManus DP. Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol. 2008; 181:6679-6685.
139. Gottstein B, Piarroux R. Current trends in tissue-affecting helminths. Parasite. 2008; 15:291-298.